Overview

Pregabalin add-on for Neuropathic Pain in Cervical Myelopathy

Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
There is no information on the effect of pregabalin in patients with neuropathic pain in cervical myelopathy under routine clinical practice. The investigators will conduct this prospective, randomized trial to determine the efficacy of pregabalin for neuropathic pain in cervical myelopathic patients in order to validate or refute this popular practice. The primary aim of this study was to compare Leeds assessment of neuropathic symptoms and signs scale (LANSS) scores of neuropathic pain in cervical myelopathy patients.
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Analgesics, Opioid
Pregabalin